Azitra Inc (AZTR)

$0.18 -0.01 (-6.97%)
Market Cap 3.20M
Revenue (ttm) 0.00
Net Income (ttm) -10.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 850,800
Avg Vol 555,176
Day's Range N/A - N/A
Shares Out 16.19M
Stochastic %K 10%
Beta -1.30
Analysts Strong Sell
Price Target $0.78

Company Profile

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically m...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 646 6446
Address:
21 Business Park Drive, Branford, United States
ItsToolTime
ItsToolTime Jun. 17 at 4:39 PM
$AZTR F’ it, I’m in this much volume. Should see this above .25 🤷‍♂️
0 · Reply
Fuuuuu
Fuuuuu Jun. 17 at 4:19 PM
$AZTR
0 · Reply
Hassan77
Hassan77 Jun. 17 at 4:02 PM
$AZTR I dont see this getting another pop today unless its AH’s should have exploded up again by now with this volume..
0 · Reply
Hassan77
Hassan77 Jun. 17 at 3:39 PM
$AZTR Insane that they are continually pulling and tearing down the SP with over 300,000,000 volume make it make sense
0 · Reply
RealityTrade
RealityTrade Jun. 17 at 3:36 PM
$AZTR bounce time
0 · Reply
Hassan77
Hassan77 Jun. 17 at 3:36 PM
$AZTR Congrats MM’s beautiful walkdown rigged manipulation from PM to now.
0 · Reply
Bulltrader23
Bulltrader23 Jun. 17 at 3:34 PM
$AZTR this gonna be crazy if it goes again and you got stopped out or panicked
0 · Reply
Hassan77
Hassan77 Jun. 17 at 3:30 PM
$AZTR These shameless mf’s rigging our financial markets. You can feel then fighting you to steal your money
2 · Reply
Moodymoney
Moodymoney Jun. 17 at 3:26 PM
$AZTR rejected .25 and that screwed us!!!
0 · Reply
Hassan77
Hassan77 Jun. 17 at 3:21 PM
$AZTR Got avg down to .25 with 14k shares
0 · Reply
Latest News on AZTR
Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond

Jun 17, 2026, 8:00 AM EDT - 4 hours ago

Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond

Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting

Jun 4, 2026, 4:05 PM EDT - 12 days ago

Azitra Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting

Azitra Proxy statement: Proxy filing

Jun 4, 2026, 8:00 AM EDT - 13 days ago

Azitra Proxy statement: Proxy filing

Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting

May 27, 2026, 4:30 PM EDT - 20 days ago

Azitra Announces Intention to Adjourn Annual Meeting and Reconvene Annual Meeting

Azitra Proxy statement: Proxy filing

May 27, 2026, 8:00 AM EDT - 21 days ago

Azitra Proxy statement: Proxy filing

Azitra files to sell 255.7M shares of common stock for holders

2026-05-21T21:00:49.000Z - 26 days ago

Azitra files to sell 255.7M shares of common stock for holders

Azitra Registration statement: Registration filing

May 21, 2026, 8:00 AM EDT - 27 days ago

Azitra Registration statement: Registration filing

Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates

May 13, 2026, 8:30 AM EDT - 5 weeks ago

Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates

Azitra Quarterly report: Q1 2026

May 13, 2026, 8:00 AM EDT - 5 weeks ago

Azitra Quarterly report: Q1 2026

Azitra Earnings release: Q1 2026

May 13, 2026, 8:00 AM EDT - 5 weeks ago

Azitra Earnings release: Q1 2026

Azitra Proxy statement: Proxy filing

May 8, 2026, 8:00 AM EDT - 5 weeks ago

Azitra Proxy statement: Proxy filing

Azitra granted new U.S. patent protecting ATR-12 program

2026-05-07T06:25:51.000Z - 5 weeks ago

Azitra granted new U.S. patent protecting ATR-12 program

Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program

May 6, 2026, 8:00 AM EDT - 6 weeks ago

Azitra, Inc. Announces New U.S. Patent Protecting ATR-12 Program

Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris

Apr 28, 2026, 8:02 AM EDT - 7 weeks ago

Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris

Azitra Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 7 weeks ago

Azitra Proxy statement: Proxy filing

Why Is Azitra Inc Stock (AZTR) Up Today?

2026-03-21T00:36:00.000Z - 3 months ago

Why Is Azitra Inc Stock (AZTR) Up Today?

Azitra Inc trading resumes

2026-03-19T17:45:16.000Z - 3 months ago

Azitra Inc trading resumes

Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million

Mar 19, 2026, 1:13 PM EDT - 3 months ago

Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million

Azitra Inc trading halted, news pending

2026-03-19T16:25:35.000Z - 3 months ago

Azitra Inc trading halted, news pending

Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement

Mar 13, 2026, 5:15 PM EDT - 3 months ago

Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement

Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders

Mar 5, 2026, 4:30 PM EST - 3 months ago

Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders

Azitra Proxy statement: Proxy filing

Mar 5, 2026, 7:00 AM EST - 3 months ago

Azitra Proxy statement: Proxy filing

Azitra Slides: Corporate presentation

Mar 2, 2026, 7:00 AM EST - 3 months ago

Azitra Slides: Corporate presentation

Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

Feb 27, 2026, 5:30 PM EST - 3 months ago

Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

Azitra Annual report: Q4 2025

Feb 27, 2026, 7:00 AM EST - 3 months ago

Azitra Annual report: Q4 2025

Azitra Earnings release: Q4 2025

Feb 27, 2026, 7:00 AM EST - 3 months ago

Azitra Earnings release: Q4 2025

Azitra adds MD Anderson Cancer Center as site for Phase 1/2 skin rash trial

2026-02-24T13:12:53.000Z - 4 months ago

Azitra adds MD Anderson Cancer Center as site for Phase 1/2 skin rash trial

Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash

Feb 24, 2026, 8:00 AM EST - 4 months ago

Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash

Azitra, Inc. to Present at BIO Investment & Growth Summit

Feb 19, 2026, 8:00 AM EST - 4 months ago

Azitra, Inc. to Present at BIO Investment & Growth Summit

Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting

Feb 6, 2026, 4:15 PM EST - 4 months ago

Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting

Azitra Proxy statement: Proxy filing

Feb 6, 2026, 7:00 AM EST - 4 months ago

Azitra Proxy statement: Proxy filing

Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 5 months ago

Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

Azitra Proxy statement: Proxy filing

Jan 2, 2026, 7:00 AM EST - 5 months ago

Azitra Proxy statement: Proxy filing

Azitra Proxy statement: Proxy filing

Dec 23, 2025, 7:00 AM EST - 6 months ago

Azitra Proxy statement: Proxy filing

Azitra says NYSE American approves compliance plan

2025-12-17T21:16:09.000Z - 6 months ago

Azitra says NYSE American approves compliance plan

Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

Dec 17, 2025, 4:10 PM EST - 6 months ago

Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

Azitra files to sell 38.9M shares of common stock for holders

2025-12-10T21:16:02.000Z - 6 months ago

Azitra files to sell 38.9M shares of common stock for holders

Azitra Registration statement: Registration filing

Dec 10, 2025, 7:00 AM EST - 6 months ago

Azitra Registration statement: Registration filing

Azitra prices 4.69M share private placement at 32c per share

2025-11-24T14:20:36.000Z - 7 months ago

Azitra prices 4.69M share private placement at 32c per share

Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules

Nov 24, 2025, 9:00 AM EST - 7 months ago

Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules

Azitra Slides: Corporate presentation

Nov 13, 2025, 7:00 AM EST - 7 months ago

Azitra Slides: Corporate presentation

Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates

Nov 12, 2025, 5:15 PM EST - 7 months ago

Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates

Azitra Quarterly report: Q3 2025

Nov 12, 2025, 7:00 AM EST - 7 months ago

Azitra Quarterly report: Q3 2025

Azitra Earnings release: Q3 2025

Nov 12, 2025, 7:00 AM EST - 7 months ago

Azitra Earnings release: Q3 2025

Azitra says report of $44M registered direct offering is false

2025-11-07T11:10:47.000Z - 7 months ago

Azitra says report of $44M registered direct offering is false

Azitra, Inc. Addresses False Report Regarding Sale of Securities

Nov 7, 2025, 6:00 AM EST - 7 months ago

Azitra, Inc. Addresses False Report Regarding Sale of Securities

Azitra to present preclinical progress for its ATR-01 program

2025-10-20T12:10:25.000Z - 8 months ago

Azitra to present preclinical progress for its ATR-01 program

Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris

Oct 20, 2025, 8:02 AM EDT - 8 months ago

Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris

Azitra receives noncompliance notification from NYSE

2025-10-03T20:55:06.000Z - 9 months ago

Azitra receives noncompliance notification from NYSE

Azitra Receives Notice of Non-Compliance from NYSE American

Oct 3, 2025, 4:45 PM EDT - 9 months ago

Azitra Receives Notice of Non-Compliance from NYSE American

Azitra price target lowered to $4 from $13.32 at Maxim

2025-09-24T12:05:22.000Z - 9 months ago

Azitra price target lowered to $4 from $13.32 at Maxim

Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 8:10 AM EDT - 10 months ago

Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Azitra Registration statement: Registration filing

Aug 29, 2025, 8:00 AM EDT - 10 months ago

Azitra Registration statement: Registration filing

Azitra Stock (AZTR) Rockets on Clinical Trial Update

2025-08-28T01:25:00.000Z - 10 months ago

Azitra Stock (AZTR) Rockets on Clinical Trial Update

Azitra doses first patient in Phase 1/2 clinical trial of ATR04-484

2025-08-27T12:15:18.000Z - 10 months ago

Azitra doses first patient in Phase 1/2 clinical trial of ATR04-484

Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash

Aug 27, 2025, 8:10 AM EDT - 10 months ago

Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash

Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates

Aug 11, 2025, 5:00 PM EDT - 11 months ago

Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates

Azitra authorizes reverse 1-for-6.66 stock split

2025-08-11T20:21:05.000Z - 11 months ago

Azitra authorizes reverse 1-for-6.66 stock split

Azitra, Inc. Announces Reverse Stock Split

Aug 11, 2025, 4:15 PM EDT - 11 months ago

Azitra, Inc. Announces Reverse Stock Split

Azitra Quarterly report: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 11 months ago

Azitra Quarterly report: Q2 2025

Azitra Earnings release: Q2 2025

Aug 11, 2025, 8:00 AM EDT - 11 months ago

Azitra Earnings release: Q2 2025

Azitra files to sell 2.25M shares of common stock for holders

2025-07-19T02:20:09.000Z - 11 months ago

Azitra files to sell 2.25M shares of common stock for holders

Azitra Registration statement: Registration filing

Jul 18, 2025, 8:00 AM EDT - 11 months ago

Azitra Registration statement: Registration filing

Azitra Proxy statement: Proxy filing

Jun 18, 2025, 8:00 AM EDT - 1 year ago

Azitra Proxy statement: Proxy filing

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome

Jun 17, 2025, 8:02 AM EDT - 1 year ago

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome

Azitra, Inc. Announces Presentation at the 2025 BIO International Convention

Jun 10, 2025, 8:33 AM EDT - 1 year ago

Azitra, Inc. Announces Presentation at the 2025 BIO International Convention

Azitra Proxy statement: Proxy filing

May 29, 2025, 8:00 AM EDT - 1 year ago

Azitra Proxy statement: Proxy filing

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

May 28, 2025, 8:33 AM EDT - 1 year ago

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

Azitra Proxy statement: Proxy filing

May 19, 2025, 8:00 AM EDT - 1 year ago

Azitra Proxy statement: Proxy filing

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

May 14, 2025, 4:05 PM EDT - 1 year ago

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

May 13, 2025, 5:06 PM EDT - 1 year ago

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

Azitra Quarterly report: Q1 2025

May 13, 2025, 8:00 AM EDT - 1 year ago

Azitra Quarterly report: Q1 2025

Azitra Earnings release: Q1 2025

May 13, 2025, 8:00 AM EDT - 1 year ago

Azitra Earnings release: Q1 2025

Azitra Registration statement: Registration filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Azitra Registration statement: Registration filing

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Apr 25, 2025, 8:33 AM EDT - 1 year ago

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Apr 24, 2025, 4:05 PM EDT - 1 year ago

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Azitra to Present at Microbiome Times Partnering Forum

Mar 12, 2025, 8:33 AM EDT - 1 year ago

Azitra to Present at Microbiome Times Partnering Forum

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Feb 24, 2025, 8:30 AM EST - 1 year ago

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Azitra Annual report: Q4 2024

Feb 24, 2025, 7:00 AM EST - 1 year ago

Azitra Annual report: Q4 2024

Azitra Earnings release: Q4 2024

Feb 24, 2025, 7:00 AM EST - 1 year ago

Azitra Earnings release: Q4 2024

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Feb 4, 2025, 2:20 PM EST - 1 year ago

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Feb 3, 2025, 9:05 AM EST - 1 year ago

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Azitra, Inc. to Present at The Microcap Conference

Jan 27, 2025, 4:05 PM EST - 1 year ago

Azitra, Inc. to Present at The Microcap Conference

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Jan 15, 2025, 8:30 AM EST - 1 year ago

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Azitra Announces Proposed Public Offering of Common Stock

Jan 14, 2025, 4:05 PM EST - 1 year ago

Azitra Announces Proposed Public Offering of Common Stock

Azitra Proxy statement: Proxy filing

Jan 14, 2025, 7:00 AM EST - 1 year ago

Azitra Proxy statement: Proxy filing

Azitra Proxy statement: Proxy filing

Jan 14, 2025, 7:00 AM EST - 1 year ago

Azitra Proxy statement: Proxy filing

Azitra Proxy statement: Proxy filing

Jan 3, 2025, 7:00 AM EST - 1 year ago

Azitra Proxy statement: Proxy filing

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Nov 12, 2024, 5:05 PM EST - 1 year ago

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Azitra Quarterly report: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Azitra Quarterly report: Q3 2024

Azitra Earnings release: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Azitra Earnings release: Q3 2024

Azitra to Present at BIO-Europe 2024

Oct 29, 2024, 9:00 AM EDT - 1 year ago

Azitra to Present at BIO-Europe 2024

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 11, 2024, 9:00 AM EDT - 1 year ago

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Azitra Proxy statement: Proxy filing

Oct 9, 2024, 8:00 AM EDT - 1 year ago

Azitra Proxy statement: Proxy filing

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Sep 24, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Sep 18, 2024, 9:00 AM EDT - 1 year ago

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 6, 2024, 4:30 PM EDT - 1 year ago

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 28, 2024, 8:30 AM EDT - 1 year ago

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Aug 22, 2024, 9:00 AM EDT - 1 year ago

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 20, 2024, 4:15 PM EDT - 1 year ago

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates

Aug 12, 2024, 6:23 PM EDT - 2 years ago

Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates

Azitra Quarterly report: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Azitra Quarterly report: Q2 2024

Azitra Earnings release: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Azitra Earnings release: Q2 2024

CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering

Jul 25, 2024, 5:57 PM EDT - 2 years ago

CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering

You.com Announces Strategic Collaboration With Moesif to Drive Productivity and Power Usage-Based Billing

Jul 25, 2024, 1:54 PM EDT - 2 years ago

You.com Announces Strategic Collaboration With Moesif to Drive Productivity and Power Usage-Based Billing

HAL

ItsToolTime
ItsToolTime Jun. 17 at 4:39 PM
$AZTR F’ it, I’m in this much volume. Should see this above .25 🤷‍♂️
0 · Reply
Fuuuuu
Fuuuuu Jun. 17 at 4:19 PM
$AZTR
0 · Reply
Hassan77
Hassan77 Jun. 17 at 4:02 PM
$AZTR I dont see this getting another pop today unless its AH’s should have exploded up again by now with this volume..
0 · Reply
Hassan77
Hassan77 Jun. 17 at 3:39 PM
$AZTR Insane that they are continually pulling and tearing down the SP with over 300,000,000 volume make it make sense
0 · Reply
RealityTrade
RealityTrade Jun. 17 at 3:36 PM
$AZTR bounce time
0 · Reply
Hassan77
Hassan77 Jun. 17 at 3:36 PM
$AZTR Congrats MM’s beautiful walkdown rigged manipulation from PM to now.
0 · Reply
Bulltrader23
Bulltrader23 Jun. 17 at 3:34 PM
$AZTR this gonna be crazy if it goes again and you got stopped out or panicked
0 · Reply
Hassan77
Hassan77 Jun. 17 at 3:30 PM
$AZTR These shameless mf’s rigging our financial markets. You can feel then fighting you to steal your money
2 · Reply
Moodymoney
Moodymoney Jun. 17 at 3:26 PM
$AZTR rejected .25 and that screwed us!!!
0 · Reply
Hassan77
Hassan77 Jun. 17 at 3:21 PM
$AZTR Got avg down to .25 with 14k shares
0 · Reply
roadtoapenny
roadtoapenny Jun. 17 at 3:18 PM
$AZTR took my stop loss. -15% on this smh
0 · Reply
Hassan77
Hassan77 Jun. 17 at 3:13 PM
$AZTR I feel like we are about to get fucked with an all day slow bleed but im still holding
0 · Reply
FkDisManipulation
FkDisManipulation Jun. 17 at 3:12 PM
$AZTR fkn joos Gave up all profit... Only got +58.71
0 · Reply
god_zilla237
god_zilla237 Jun. 17 at 3:11 PM
$AZTR dead stock
0 · Reply
Bulltrader23
Bulltrader23 Jun. 17 at 3:11 PM
$AZTR it’ll go a little bit and down if you were at the top and just be patient
0 · Reply
DayTrade_4Life
DayTrade_4Life Jun. 17 at 3:09 PM
🤑Another AMAZING day. They don't stop. 💪From the Watchlist and Alerts Today 17 June 26: 👉Don't miss out any longer. See Link in Profile and check us out. ICCM: 3.55 to 9.54 (168%) EHGO: 3.50 to 8.05 (130%) CLWT 2.35 to $5 (112%) UTSI: $5 to 9.98 (99%) CIIT: .65 to 1.05 (61%) $SNBR: .32 to .49 (53%) $AZTR: .31 to .48 (52%) $NIVF: 1.20 to 1.79 (49%) $CRE: $5 to 7.11 (42%) $LNAI: 5.55 to 7.90 (42%) ELTX: $3 to 3.71 (23%)
0 · Reply
Hassan77
Hassan77 Jun. 17 at 3:07 PM
$AZTR All other stocks that pumped PM had their secondary bounce but us…wow
1 · Reply
Bulltrader23
Bulltrader23 Jun. 17 at 3:06 PM
$AZTR .27?
0 · Reply
OPENARMY
OPENARMY Jun. 17 at 3:01 PM
$AZTR al need to contribute to push past 0.26 to get back over 0.30
0 · Reply
Bulltrader23
Bulltrader23 Jun. 17 at 2:55 PM
$AZTR pump it 🫡🐂
0 · Reply
kfuman1
kfuman1 Jun. 17 at 2:49 PM
$AZTR It's right back to its average for the last three months. Since the last pump and dump...
0 · Reply
tankgangsta
tankgangsta Jun. 17 at 2:46 PM
$AZTR this is gonna get good
0 · Reply